- $50.27m
- $67.37m
- $22.36m
DarioHealth Corp reports results for the quarter ended in September 30 - Earnings Summary
Brief: DarioHealth Reports Q3 2024 Financial And Operating Results
DarioHealth Corp expected to post a loss of 27 cents a share - Earnings Preview
Brief: DarioHealth On Sept 16, Received Notice From Nasdaq Indicating Co Was Not In Compliance With A Nasdaq Listing Rule
U.S. RESEARCH ROUNDUP-Autodesk, Crowdstrike, Oshkosh
DarioHealth Corp reports results for the quarter ended in June - Earnings Summary
DarioHealth Corp expected to post a loss of 56 cents a share - Earnings Preview
Brief: Dario Expands Glp-1 Solution Client Base With New Employer Contract
Brief: Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer
U.S. STOCKS ON THE MOVE-MakeMyTrip, WaFd, Bolt Biotherapeutics
U.S. STOCKS ON THE MOVE-Dell, Biogen, Canoo
DarioHealth falls after Q1 revenue misses estimates
DarioHealth Corp reports results for the quarter ended in March - Earnings Summary
DarioHealth Corp expected to post a loss of 40 cents a share - Earnings Preview
DarioHealth Corp expected to post a loss of 40 cents a share - Earnings Preview
Brief: Dario Signs Two Employers For Cardiometabolic Suite With Integrated GLP-1 Solution
DarioHealth Corp reports results for the quarter ended in December - Earnings Summary
DarioHealth Corp expected to post a loss of 54 cents a share - Earnings Preview
Brief: Dario Acquires Twill Creating Comprehensive Digital Health Platform Across Most Prevalent Chronic Conditions